Updates matching "Access to Health Care"

Nashville, TN – August 9, 2019 – Tennessee is falling short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer according to the latest edition of How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer

The Center for Medicare and Medicaid Services (CMS) issued guidance last night giving Medicare Advantage plans the option of applying step therapy for physician-administered and other Part B drugs, effective January 1, 2019.

Today the American Cancer Society Cancer Action Network submitted comments to the Department of Health and Human Services (HHS) regarding proposals to reduce prescription drug costs outlined in the administration’s Request for Information (RFI) regarding its Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (blueprint).

HURST, Texas – State Sen. Kelly Hancock (R-North Richland Hills) on Thursday received the American Cancer Society Cancer Action Network’s Advocacy in Action Award in recognition of his leadership to ensure Texans facing cancer do not also face health risks associated with step therapy, also known as “fail first”

The Centers for Medicare and Medicaid Services (CMS) announced today that they will not approve Massachusetts’ request to restrict Medicaid prescription drug coverage to as few as one drug per class—a practice commonly called a “closed formulary”—unless a state foregoes all manufacturer rebates.

The Department of Labor issued final rules governing the creation of association health plans. Under the rule, AHPs would be exempt from current benefit and cost-sharing requirements.

Patient groups representing millions of Americans with pre-existing conditions filed an amicus curiae or friend of the court brief in the U.S. District Court case, Texas v. United States , citing the devastating impact patients would face should the court side with plaintiffs and move to invalidate the Affordable Care Act.